Previous studies showed that in the intestine, IL-36α and IL-36γ expression is upregulated in IBD patients, and experiments using a murine dextran sodium sulfate colitis model showed that the IL-36R signaling pathway plays an important role modulating intestinal fibrosis in chronic inflammation [11,27,29,30,31,32]. This evidence concerns the gene IL36A and inflammatory bowel disease.